Melissa Hackel - Infinity Pharmaceuticals Insider

Infinity Pharmaceuticals Inc -- USA Stock  

USD 1.80  0.04  2.17%

Vice President - Finance

Ms. Melissa Hackel serves as Vice President Finance of the Company. Melissa Hackel joined Infinity in 2015 and has more than 15 years of financial experience in the pharmaceutical and medical device industry and has made financial and operational contributions throughout her career leading and developing teams to manage financial analysis in support of strategic decisionmaking. Prior to joining Infinity, Ms. Hackel served as director of finance at Takeda Pharmaceutical Company. She received a MBA from Duke University and a B.A. in political science from Bates College.
  President Since 2017  MBA    
617-453-1000  http://www.infi.com

Management Efficiency

The company has return on total asset (ROA) of (27.38) % which means that it has lost $27.38 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (73.91) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 6 M in liabilities with Debt to Equity (D/E) ratio of 11.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Infinity Pharmaceuticals Inc has Current Ratio of 5.76 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 5 records

PRESIDENT Since

Athena KartsaklisVBI Vaccines Inc
2017
Eyal BreitbartVascular Biogenics Ltd
2014
Erez FeigeVascular Biogenics Ltd
2014
Yael CohenVascular Biogenics Ltd
2008
Adam BuckleyVBI Vaccines Inc
N/A

Entity Summary

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for patients with difficult-to-treat diseases in the United States. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuticals operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 56 people.Infinity Pharmaceuticals Inc (INFI) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 56 people. Infinity Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Infinity Pharmaceuticals Inc to your portfolio

Top Management

Infinity Pharmaceuticals Leadership Team
Joseph Pearlberg, President, Ph.D
Melissa Hackel, President, MBA
William Bertrand, President
Vito Palombella, EVP
Jeffrey Berkowitz, Director
Lawrence Bloch, President, MBA
Norman Selby, Director, MBA
Jose Baselga, Director, Ph.D
Michael Venuti, Director, Ph.D
Michael Kauffman, Director
Eric Lander, Director, Ph.D
Julian Adams, President
Anthony Evnin, Director, Ph.D
Gwendolyn Fyfe, Director
Sujay Kango, President, MBA
Ian Smith, Director
Adelene Perkins, Chairman, MBA

Stock Performance

Infinity Pharmaceuticals Performance Indicators